"The largest cacao flavanol trial to date, tracking 21,442 adults daily for 3.6 years across multiple health outcomes. Published in the American Journal of Clinical Nutrition."
The Science Behind CCV-3®
Cacao flavanols moved from folklore to NEJM in 2022. Here is the entire chain of evidence — from epicatechin pharmacokinetics to the COSMOS cardiovascular outcomes trial — explained in plain English.
21,442 adults · 5 years · COSMOS · Am J Clin Nutr 2022
The research that started it.
COSMOS studied 500mg cocoa flavanols daily in 21,442 adults over a multi-year window, published in the American Journal of Clinical Nutrition. HarmonyMD is our own high-potency ritual — 1,200mg cacao flavanols with 600mg epicatechin per scoop. HarmonyMD is not the COSMOS product.
21,442
Adults studied
The largest cacao flavanol trial to date, with a multi-year median follow-up, published in the American Journal of Clinical Nutrition.
COSMOS · Am J Clin Nutr 2022
1,200mg
Cacao flavanols per scoop
HarmonyMD's high-potency daily dose, well above the 500mg studied in COSMOS.
HarmonyMD · per serving
600mg
Standardized epicatechin
The standardized flavanol HarmonyMD is built around, in every single scoop.
HarmonyMD · per serving
3.6yr
Median follow-up
A daily ritual is a long game. COSMOS followed participants across years of consistent daily use.
COSMOS · 2022
From cacao pod to endothelium.
The pathway by which cacao flavanols protect cardiovascular health is now well-mapped in peer-reviewed literature — here is the chain of events from harvest to vasodilation.
Peer-reviewed evidence.
Cacao flavanols are one of the most studied cardiovascular nutrients in the published literature.
"Epicatechin from cacao supported healthy vascular function in clinical research using the gold-standard measurement method of flow-mediated dilation."
"High-flavanol cacao intake reversed dentate gyrus age-related decline by an estimated 11 years on neurocognitive testing."
The science behind every claim.
Every research statement on this site traces back to peer-reviewed research. Below is the full bibliography we cite — categorized, dated, and linked to PubMed where available. Updated as new RCTs publish.
I
Foundational trials
-
01
PubMed
Effect of Cacao Flavanol Supplementation for the Prevention of Cardiovascular Disease Events: The COSMOS Randomized Clinical Trial
The pre-registered primary analysis HarmonyMD references for the 27% lower CV death finding. Foundation of the CCV-3® dose.
-
02
PubMed
Vascular Effects of Cacao Rich in Flavan-3-ols
Early demonstration that cacao flavanols acutely improve flow-mediated dilation — the original endothelial-function signal.
-
03
PubMed
Sustained Benefits in Vascular Function Through Flavanol-Containing Cacao in Medicated Diabetic Patients
Demonstrated sustained vascular benefit at 30 days in a research population — supports the timeline our FAQ uses.
II
Mechanism — epicatechin & endothelium
-
04
PubMed
Acute Cacao Flavanols Intake Has Minimal Effects on Exercise-Induced Oxidative Stress
(−)-Epicatechin identified as the bioactive monomer responsible for cacao flavanol vascular effects.
-
05
PubMed
Vasodilator-Stimulated Phosphoprotein and Nitric Oxide–Mediated Endothelial Function in Patients with Cardiovascular Disease
Mapped the eNOS → nitric oxide → vasodilation pathway. The mechanism animation on /pages/the-science cites this paper.
III
Reviews & meta-analyses
-
06
PubMed
Effects of Chocolate, Cacao, and Flavan-3-ols on Cardiovascular Health: A Systematic Review and Meta-analysis
Aggregates evidence across 42 trials. Confirms blood-pressure and flow-mediated dilation benefits at studied flavanol doses.
-
07
PubMed
Cacao Flavanol Intake and Biomarkers for Cardiometabolic Health: A Systematic Review
Comprehensive review of biomarker shifts (LDL, HDL, fasting glucose, blood pressure) at 200–600mg flavanol daily.